Figures computed from official regulatory filings — .
Statistical track record
FreeWin rates and median returns are available with a free account (5 insiders/month).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Details | |
|---|---|---|---|---|
RELMADA THERAPEUTICS, INC.Listing on record | Buy | $339.2K | SEC | |
RELMADA THERAPEUTICS, INC.Listing on record | Buy | $504.8K | SEC | |
RELMADA THERAPEUTICS, INC.Listing on record | AwardD (derivative) | — | SEC | |
RELMADA THERAPEUTICS, INC.Listing on record | Buy | $48.1K | SEC | |
RELMADA THERAPEUTICS, INC.Listing on record | Buy | $1.1M | SEC | |
RELMADA THERAPEUTICS, INC.Listing on record | AwardD (derivative) | — | SEC | |
RELMADA THERAPEUTICS, INC.Listing on record | Buy | $31.2K | SEC | |
RELMADA THERAPEUTICS, INC.Listing on record | Buy | $44.1K | SEC | |
RELMADA THERAPEUTICS, INC.Listing on record | Buy | $22K | SEC | |
RELMADA THERAPEUTICS, INC.Listing on record | Buy | $20.9K | SEC | |
RELMADA THERAPEUTICS, INC.Listing on record | Buy | $57.7K | SEC | |
RELMADA THERAPEUTICS, INC.Listing on record | Buy | $71.2K | SEC | |
RELMADA THERAPEUTICS, INC.Listing on record | OtherD (derivative) | — | SEC | |
RELMADA THERAPEUTICS, INC.Listing on record | AwardD (derivative) | — | SEC | |
RELMADA THERAPEUTICS, INC.Listing on record | Buy | $27.9K | SEC | |
RELMADA THERAPEUTICS, INC.Listing on record | Buy | $58.4K | SEC | |
RELMADA THERAPEUTICS, INC.Listing on record | Buy | $39.4K | SEC | |
RELMADA THERAPEUTICS, INC.Listing on record | AwardD (derivative) | — | SEC | |
RELMADA THERAPEUTICS, INC.Listing on record | AwardD (derivative) | — | SEC | |
RELMADA THERAPEUTICS, INC.Listing on record | OtherD (derivative) | — | SEC | |
RELMADA THERAPEUTICS, INC.Listing on record | AwardD (derivative) | — | SEC | |
RELMADA THERAPEUTICS, INC.Listing on record | AwardD (derivative) | — | SEC | |
RELMADA THERAPEUTICS, INC.Listing on record | AwardD (derivative) | — | SEC | |
RELMADA THERAPEUTICS, INC.Listing on record | AwardD (derivative) | — | SEC | |
RELMADA THERAPEUTICS, INC.Listing on record | Sell | $64.8K | SEC |